Enorama Pharma AB (publ)

Stockholm Stock Exchange ERMA.ST

Enorama Pharma AB (publ) Dividends Paid for the year ending December 31, 2023: USD 0.00

Enorama Pharma AB (publ) Dividends Paid is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Enorama Pharma AB (publ) Dividends Paid for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
Enorama Pharma AB (publ) Dividends Paid for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
Enorama Pharma AB (publ) Dividends Paid for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
Enorama Pharma AB (publ) Dividends Paid for the year ending December 31, 2019 was USD 0.00, a 0.00% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Stockholm Stock Exchange: ERMA.ST

Enorama Pharma AB (publ)

CEO	Mr. Daniel Schroder
IPO Date	June 10, 2016
Location	Sweden
Headquarters	Södergatan 3
Employees	5
Sector	Health Care
Industries Pharmaceuticals Tobacco

Description

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.

Key trends

Past 5 years